Image

A Study to Evaluate Corneal Endothelial Cell Density (ECD) in Subjects With Dry Eye Disease (DED) Administering Miebo® (Perfluorohexyloctane Ophthalmic Solution) for 12 Months.

We're studying eye health in dry eye patients using Miebo® drops.

Recruiting
18 years and older
All
Phase 4
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study is to understand how Dry Eye Disease (DED) affects the cornea, the clear front surface of your eye. The Corneal Endothelial Cell Density (ECD) measures how many cells are in this part of your eye. The eye drops being tested are called Miebo® (Perfluorohexyloctane Ophthalmic Solution). They will be compared to a placebo, which is a harmless solution like saline, over 12 months.

To join, you must be 18 or older and have had DED for at least 6 months. You should also have a specific level of eye cell health, and agree to stop wearing contact lenses during the study. You should not have any eye conditions or surgeries that might interfere with the study. Pregnant or nursing women, or those planning a pregnancy, cannot participate.

  • **Duration:** Participation lasts 12 months.
  • **Visits:** Requires regular visits for check-ups.
  • **Risks:** You may experience side effects like irritation.

Your participation helps us learn more about how to treat DED effectively.

Print
Study details
    Dry Eye

NCT06565650

Bausch & Lomb Incorporated

13 December 2024

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race
Ethnicity
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.